Skip to content
healthcare.dev

Vasopressin

NDC 25021-474, Vasopressin, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-474
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA216963
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VASOPRESSIN20 [USP'U]/mL

Pharmacologic classes

Decreased Diuresis [PE]; Vasoconstriction [PE]; Vasopressins [CS]

Package NDCNDC-11Package
25021-474-012502104740125 VIAL in 1 CARTON (25021-474-01) / 1 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ad3ac280-49da-4816-9097-14517d0c0f85
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-474

Use it

Look up 25021-474 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-474. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.